Searching recalls…
Searching…
Searching…
Home › Prescription medicine › Par Health Issues Voluntary Nationwide Recall…
Check whether yours is affected, and ask your pharmacist or doctor before changing anything.
FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose.
The Recall Registry rates this worth checking — we found nothing in the notice describing a specific injury. A recall covers only the versions, UPCs or date codes it names, so check those against yours.
Read the full announcement on FDA.gov using the link below — it lists the affected lots and what the company is offering.
Who to contact: Announced by Par Health
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine
Otsuka ICU Medical LLC is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Injection, USP, 100mL single pack to the user level due to a…